A tumour gene's fatal flaws
- 4 November 2009
- journal article
- editorial
- Published by Springer Nature in Nature
- Vol. 462 (7269) , 44-45
- https://doi.org/10.1038/462044a
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinomaNature, 2009
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1Nature, 2009
- Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer CellsCell, 2009
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras OncogeneCell, 2009
- Is NF-κB a good target for cancer therapy? Hopes and pitfallsNature Reviews Drug Discovery, 2009
- Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersNature Medicine, 2008
- Regulation and Function of IKK and IKK-Related KinasesScience's STKE, 2006
- RalB GTPase-Mediated Activation of the IκB Family Kinase TBK1 Couples Innate Immune Signaling to Tumor Cell SurvivalCell, 2006
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic RasScience, 1997